3,7,11,15,18,22,26,30-octamethyldotriacontane-1,32-diol(99529-30-3)
- Name: 3,7,11,15,18,22,26,30-octamethyldotriacontane-1,32-diol
- Synonyms:3R,7R,11R,15S,18S,22R,26R,30R-Octamethyldotriacontane-1,32-diol;3,7,11,15,18,22,26,30-Octamethyldotriacontane-1,32-diol;OMDTC;
- Molecular Formula:C40H82O2
- Molecular Weight:595.0779
- CAS Registry Number:99529-30-3
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 41736-95-2/adamantane diazirine
- 93892-35-4/4,6-Dicyclopentyl-1,1,3-trimethylindan-5-ol
- 54143-31-6/7-oxo-8-aza-7-azoniabicyclo[4.2.2]decan-8-olate
- 39994-77-9/pentyl naphthalen-1-ylcarbamate
- 30855-47-1/1-[(5-aminopyrimido[5,4-e][1,2,4]triazin-3-yl)methyl]triaza-1,2-dien-2-ium
- 38776-54-4/3'H-Cyclopropa[6,7]-1,5-cycloandrost-6-ene,6,- 7-dihydro-
- 78691-22-2/insulin, des-Gly(1A)-N-((trimethylammonio)acetyl)Ile(2A)-
- 683-53-4/2-Bromo-1,1-dichloroethane
- 159138-81-5/Benzamide,N-(aminoiminomethyl)-4-(1- methylethyl)-3-(methylsulfonyl)-,monomethanesulfonate
- 4372-39-8/(diphenylmethyl)propanedioic acid
- 64183-27-3/2'-Fluoro-2'-deoxyadenosine
- 5525-40-6/(4-broMophenyl)diphenylphosphine oxide
- 363-23-5/13,14-DIHYDRO-15-KETO PROSTAGLANDIN E2
- 52591-11-4/9-Hydroxy-7-(4-hydroxy-3-methoxyphenyl)-8H-1,3-dioxolo[4,5-g][1]benzopyran-8-one
- 120126-88-7/(2S)-2-({[(5S,6R)-13-amino-1,6,8-trihydroxy-5-{[(2S,3R,4S,5S,6R)-3-hydroxy-6-methyl-5-(methylamino)-4-{[(2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl]oxy}tetrahydro-2H-pyran-2-yl]oxy}-11-methoxy-3-methyl-9,14-dioxo-5,6,9,14-tetrahydrobenzo[a]tetr
- 4562-20-3/[[2-[2-(2,6-dioxo-4-piperidyl)-1-hydroxy-ethyl]-4,6-dimethyl-cyclohexy lidene]amino]thiourea
- 174916-21-3/2(5H)-Furanone,3-[(8R,11R)-8,11-dihydroxy- 11-[(2R,2'R,5R,5'R)-octahydro-5'-[(1R)-1- hydroxytridecyl][2,2'-bifuran]-5-yl]undecyl]- 5-methyl-,(5S)-
- 102853-43-0/3-(2-aminoethyl)-1H-indole-5,6-diol; 2-amino-1-methyl-5H-imidazol-4-one; sulfuric acid
- 43205-82-9/p-Mentha-1-ene-6-one
- 99529-30-3/3,7,11,15,18,22,26,30-octamethyldotriacontane-1,32-diol
- 1915-78-2/3-(4-chloro-2-methylphenyl)-2-methylquinazolin-4(3H)-one
- 127718-40-5/(6Z)-6-([2-(2-methylphenyl)hydrazinyl]{(E)-[(4-phenylpiperazin-1-yl)acetyl]diazenyl}methylidene)cyclohexa-2,4-dien-1-one
- 130722-20-2/Spiro[furan-2(5H),2'-[2H,11H-6a,8a]methanooxepino[4,3-c]pyrano[3',2':3,4]cyclopenta[1,2-h][1,2]benzodioxocin]-5,11'-dione,3,3',4,4',4'a,4'b,5',6',13',13'a,14',15',15'a,15'b,16',16'a-hexadecahydro-4,4',4'b,13',13',15'b-hexamethyl-,(2S,4R,4'R,4'aR,4'bR,6'aS,8'aS,13'aS,15'aS,15'bS,16'aR)- (9CI)
- 41240-22-6/tetradecanylglutarate
- 84732-27-4/4-{[2-(acryloyloxy)ethoxy]carbonyl}benzene-1,3-dicarboxylic acid
- 5424-63-5/(1E)-1-phenyl-5-pyrrolidin-1-ylpent-1-en-3-one
- 6340-55-2/2,6-DIMETHOXY-4-METHYLQUINOLINE
- 66036-61-1/SVPE 5
- 101162-62-3/cholecystokinin C-terminal flanking peptide
- 520-12-7/5,7-dihydroxy-6-methoxy-2-(4-methoxyphenyl)-4-benzopyrone